Doctors have concerns and questions about Alzheimer’s drug, Aduhelm® (Aducanumab), on the market for patients

Aduhelm® (Aducanumab) was approved by the FDA on June 7, 2021, for the treatment of Alzheimer’s disease. To learn more about Aduhelm please click here. Aduhelm® (Aducanumab) was approved by the Food and Drug Administration (FDA) on June 7, 2021. It is the first medication approved by the FDA for slowing the progression of Alzheimer’s … Read more Doctors have concerns and questions about Alzheimer’s drug, Aduhelm® (Aducanumab), on the market for patients